Cure Genetics Co., Ltd.

Industry

  • Pharmaceuticals
    • Drug Delivery
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
See more in Biomedtracker

Latest on Cure Genetics Co., Ltd.

Scrip

Asia Deal Watch: Inventiva Finds Japan/Korea Partner For Phase III NASH Candidate In Hepalys

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Hepalys Partners With Inventiva In

In Vivo

136 Years And Counting: Boehringer Ingelheim Sees Advantage In Private Structure

 
• By Joseph Haas

Although family-owned Boehringer Ingelheim GmbH is the only private firm in the top 20 largest biopharmas, its executives are quick to explain that most of their operations function in the same way

Scrip

Deal Watch: Genentech Gets Access To X-Chem’s DNA-Encoded Library Technology

 
• By Joseph Haas and John Davis

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Genentech Seeks Novel Small Molecule Ca

Scrip

Venture Funding Deals: Orchard Brings Total To $291m

 
• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmace